Multiple Endocrine Neoplasia I and II

These are rare, genetic conditions are passed down through families. They cause tumors of the parathyroid, adrenal, and thyroid glands, leading to overproduction of hormones. The cause of MEN II is a defect in a gene called RET. This defect causes many tumors to appear in the same person, but not necessarily at the same time. The disorder may occur at any age, and affects men and women equally. The main risk factor is a family history of MEN II.

Multiple endocrine neoplasias are of two types, type 1 and type 2. They are a group of disorders of endocrine system that are caused due to the development of lesions or nodules in the pituitary, parathyroid and pancreatic glands. Multiple endocrine type 1 is also known as wermers syndrome. Multiple endocrine type 2 is also known as phechromocytoma  or sipple syndrome which caused medullary thyroid carcinoma. They both are hereditary disorders which can be inherited from one generation to other generation. Type 1 and type 2 are differentiated on the basis of genes involvement. Hyperparathyroidism is the most common sign of type 1 which includes osteoporosis, pancreatic tumors including islets of Langerhans is also a common sign of the type 1 neoplasia. Pheochorocytoma and medullary thyroid carcinoma are the most common symptoms of the type 2 neoplasia. Management of MEN 2 includes thyroidectomy. The occurrence of MEN 2 is due to the variation in proto oncogene known as RET. The occurrence of MEN 1 is due to the mutation of MEN 1 gene. The person with MEN 1 is born with a mutational copy of MEN 1 gene. MEN 1 can be caused at the age of <40 years. It have a positive family history and more than one organ can be effected. MEN 2 can be effected at any age and it also has a positive family history.

  • Medullary carcinoma of thyroid
  • Pheochromocytoma
  • Parathyroid adenoma
  • Parathyroid hyperplasia
  • Treatment and medication

Related Conference of Multiple Endocrine Neoplasia I and II

July 15-16, 2020

3rd Global Diabetes Summit

Helsinki, Finland
July 15-16, 2020

28th International Diabetes and Healthcare Conference

Helsinki, Finland
July 20-21, 2020

Annual Congress on Diabetes, Metabolism and Obesity

Manila, Philippines
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

Copenhagen, Denmark
August 24-25, 2020

Global Summit on Diabetes & Endocrinology

Kyoto, Japan
August 24-25, 2020

Annual Summit on Diabetes and Endocrinology

Barcelona, Spain
September 22-23, 2020

2nd Asia Pacific Endocrinology Congress

Singapore City, Singapore
September 28-29, 2020

4th Annual Congress on Diabetes, Obesity and Its Complications

Singapore City, Singapore
October 04-05, 2020

World Summit on Blood Glucose Monitoring

Beijing, China
October 07-08, 2020

International Summit on Diabetes

Barcelona, Spain
October 14-15, 2020

World Congress on Endocrinology & Diabetes

Rome, Italy
October 14-15, 2020

Global Congress on Endocrinology and Gynecology

Sydney, Australia
October 30-31, 2020

Annual Summit on Metabolomics

Vancouver, Canada
November 09-10, 2020

International Congress and Expo on Diabetic Care

Bangkok, Thailand
November 13-14, 2020

International Conference on Diabetes and Heart Diseases

Bangkok, Thailand
November 16-17, 2020

World Congress and Expo on Diabetes

Kyoto, Japan
November 16-17, 2020

2nd Asia Pacific Diabetes and Endocrinology Congress

Brisbane, Australia
November 18-19, 2020

Annual congress on Diabetes and Endocrinology Congress

Bangkok, Thailand
December 07-08, 2020

13th World Congress on Endocrinology and Metabolic Disorders

Auckland, Newzealand

Multiple Endocrine Neoplasia I and II Conference Speakers

Recommended Sessions

Related Journals

Are you interested in